DUTCH BROS INC. (BROS): what the price requires
At today's price, DUTCH BROS INC. (BROS) is priced for today's economics sustained for ~16.8 years. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.
Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/BROS
Headline
| Field | Value |
|---|---|
| Ticker | BROS |
| Company | DUTCH BROS INC. |
| Current price | $66.58/sh |
| Composition | Company-operated shops 92% / Franchising 7% / Other 0% |
What The Price Requires (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Operating margin needed | 11.6% |
| Operating margin today | 9.7% |
| Margin expansion implied | +1.9pp |
| Must persist for | 16.8y |
| Multiple paid | 58x operating income |
The operating-margin requirement is derived from the framework's value band at year 5, a separately labeled basis from the headline growth/duration solve.
Solve inputs: computed at a 11.8% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~2.5 years.
Reconcile: at the x-ray's 9.3% required return this reads ~11 years; the models below use their own rates.
How unusual the bet is: high
| Reference | Value |
|---|---|
| vs own history | +0.55σ |
| cohort percentile (of 210 peers) | 96 |
| sustained it ~10 years at this level | 14% |
| implied end-window share | 0% |
Valuation X-Ray
Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 8.66x | 4 | expensive |
| Earnings | 9.62x | 3 | expensive |
| Relative | 1.78x | 5 | expensive |
| Growth | 0.82x | 3 | justifies |
Families that justify the price: Growth Families that call it expensive: Asset, Earnings, Relative
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.8%); the inversion above states its own rate.
Per-Model Detail (n=15)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $73.14 | 0.91x | yes | FCF base $0.2B, growth 25% (input: historical growth), terminal g 4.0%, WACC 8.8%, 7yr projection |
| DCF Exit Multiple | Growth | $81.21 | 0.82x | yes | Exit EV/EBITDA: 27.8x / 30.8x / 33.8x (bear / base = today's held flat / bull), 7yr |
| Relative Valuation | Relative | $42.51 | 1.57x | yes | P/E 51.17x (blended: static sector reference 28x + trailing (TTM) 105x), scenarios: 40.9x / 51.2x / 61.4x (bear / base = reference held flat / bull), EV/EBITDA 21.84x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $6.84 | 9.73x | yes | BV/sh $5.47, ROE (TTM) 11.6%, ke 9.3% |
| Two-Stage Excess Return | Asset | $7.61 | 8.75x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $92.73 | 0.72x | yes | Rev $1.7B, growth 28% (input: historical growth; tapered), Terminal P/S: 3.9x / 4.9x / 5.8x (bear / base = today's held flat / bull, cap 12x) |
| Peter Lynch Fair Value | Relative | $7.68 | 8.67x | yes | EPS $0.64, growth 1% (input: historical EPS growth), PEG=75.09 (Overvalued) |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $0.01 | 6658.00x | yes | Normalized EBIT (5y avg op income, one-time charges added back) $0.05B × (1−21%) / WACC 8.8% → EPV (no growth) (excluded from median) |
| Residual Income | Asset | $7.77 | 8.57x | yes | BV $5.47 + 5yr PV of (ROE (TTM) 11.6% − Kₑ 9.3%) × BV; BV grows 7.5%/yr |
| Graham Number | Asset | $8.87 | 7.51x | yes | √(22.5 × EPS $0.64 × BVPS $5.47) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | $37.34 | 1.78x | yes | EBITDA $0.29B × sector EV/EBITDA 18.0x |
| FCF Yield | Earnings | $3.88 | 17.16x | yes | FCF $90.8M / Kₑ 9.3% — zero-growth perpetuity |
| SBC-Adj FCF Yield | Earnings | $2.25 | 29.59x | yes | SBC-adj FCF $0.07B (FCF $0.09B − SBC $0.02B) capitalized at Kₑ (excluded from median) |
| Ben Graham Formula | Earnings | $20.65 | 3.22x | yes | EPS $0.64 × (8.5 + 2×15.0%) × (4.4 / 5.3%) |
| ROIC-Justified P/B | Asset | $1.42 | 46.89x | yes | BV $5.47 × (ROIC 2.3% / WACC 8.8%) (excluded from median) |
| P/Sales Sector | Relative | $61.73 | 1.08x | yes | Revenue $1.75B × sector P/S 4.5x |
| PEG Fair Value | Relative | $24.00 | 2.77x | yes | EPS $0.64 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x |
| Earnings Yield | Earnings | $6.92 | 9.62x | yes | EPS $0.64 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net debt | $352.9m |
| Net debt / NOPAT (after-tax) | 2.77x |
| Net debt / operating income (pre-tax) | 2.18x |
| Share count CAGR (dilution) | 27.6% |
| Burning cash | no |
Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.
Bullet Takeaways
At about $71, the price works out to roughly 61 times company-wide operating income. Inverted, that asks Dutch Bros to hold growth near its self-funding ceiling for something like 18 years. Historically only about one in seven comparable fast-growers sustained that pace for even a decade. The price is an explicit bet on unusually durable compounding.
The first quarter of 2026 backed the growth story: total revenue up 31% to $464 million, company-operated same-shop sales up 10.6% on 6.9% more transactions, and 41 new shops opened to reach 1,177. Management raised the full-year plan to at least 185 new shops and lifted same-store-sales guidance.
The balance sheet is built to fund the expansion. Net debt sits near $353 million, only about 2.1 times operating income, light for a company opening shops this fast. The tradeoff is dilution: the share count has been climbing, so per-share growth lags the headline revenue and shop-count growth.
Bull Case
Start with the balance sheet, because it reveals how much confidence management has in its own unit economics. Dutch Bros carries net debt of roughly $353 million, only about 2.1 times operating income, which is light for a company opening shops at the pace it is. A drive-thru coffee chain growing this fast could have leaned hard on debt to fund construction. Instead it funds most of the build internally and keeps leverage modest, which tells you the new shops pay back quickly enough that the company does not need to mortgage the future to keep expanding. The 10-K frames the runway directly: "We plan to continue to open additional company-operated shops in markets, including in" new and existing regions (FY2025 10-K, accession 0001866581-26-000006). With more than 1,100 shops today and a stated path toward roughly 2,000, the reinvestment opportunity in front of the company is large and self-funding.
The first quarter of 2026 showed the model working on both axes that matter for a unit-growth story: more shops and healthier existing shops. Total revenue rose 31% to $464 million, company-operated same-shop sales grew 10.6% with transactions up 6.9%, and systemwide same-shop sales of 8.3% were the strongest in two years. Crucially, the comp was driven by traffic, not just price, which is the harder and more durable kind of growth. Adjusted EBITDA grew 26% to $79 million, and management raised both the new-shop target, to at least 185, and the same-store-sales guide. A company beating and raising while accelerating openings is demonstrating that demand is running ahead of supply.
The newer levers extend the runway the price is paying for. Mobile Order Ahead was around 14% of the sales mix at the end of 2025, well below where mature peers sit, so there is a multi-year penetration tailwind to ticket and throughput. The food program, which started in a handful of Phoenix shops, reached over 300 shops across 11 states and is set to go nationwide by the end of 2026, with early results pointing to a roughly 4% comparable-sales lift where it runs. Against the high-growth restaurant peer set, CAVA, Shake Shack, Wingstop, Dutch Bros pairs one of the faster same-shop comps with a still-small footprint, which is exactly the combination the growth-DCF method needs to justify the price. Analysts have been raising targets into the print, with DA Davidson at $90 and UBS at $85.
Bear Case
The external variable with the most leverage on Dutch Bros is the cost of the inputs it cannot control, and the price assumes those costs stay benign for a very long time. This is a company selling discretionary coffee drinks, with margins exposed to coffee and dairy commodity prices and to wage inflation in the markets where it staffs shops. The 10-K is explicit that the squeeze is real when input prices run ahead of menu pricing: the risk arises if commodity costs "remain elevated or increase and cannot be offset by menu price increases. Additionally, if there is a time lag between increasing commodity prices and our ability to" raise prices (FY2025 10-K, accession 0001866581-26-000006). A drive-thru chain depends on repeat daily traffic, and the easiest way to lose that traffic is to keep raising prices to chase costs. The price embeds smooth compounding for roughly 18 years; a few years of commodity or labor pressure that cannot be passed through cleanly would dent the margin the model is extrapolating.
The valuation leaves no room for that. At about $71 (June 27, 2026) the price sits at roughly 61 times operating income, and only the growth-DCF family reaches it. Every static frame says richly valued: the earnings-power, asset-based, and most peer-multiple methods land in the single digits to mid-$40s, a fraction of the price. Inverted, the price requires growth held near the self-funding ceiling for about 18 years, and history says only about 14% of comparable fast-growers sustained that even for ten. This is not a stock where a good quarter is enough. It needs an exceptional decade, and the macro backdrop, discretionary spending in a consumer that can trade down to home-brewed or cheaper coffee, is exactly the kind of variable that can interrupt an exceptional decade.
Then there is dilution and the law of large numbers. The share count has been growing at a high-twenties-percent rate as the company funds growth and compensates staff with equity, so per-share value compounds more slowly than revenue or shop count. And the same-shop comp, strong as it is now, gets mechanically harder as the base of shops grows and as the food and mobile initiatives lap their first year. The stock dipped even after a beat-and-raise quarter, which is the market's way of signaling that the bar embedded in the price is extraordinarily high. When expectations are set for near-perfect execution over a decade-plus, the asymmetry tilts against the buyer: meeting the plan is already priced, and any stumble in traffic, margin, or new-shop productivity has a long way to fall.
Valuation
Dutch Bros is priced as a long-duration growth story, and the numbers make the bet explicit. At about $71 the price equals roughly 61 times company-wide operating income. Inverting that under a fixed discount and fade assumption implies operating growth held near the self-funding ceiling for around 18 years. The near-term pace is within what the company has recently delivered; the stretch is the duration. Historically only about 14% of comparable fast-growers sustained that level for even a decade, which is why the priced-in assumption reads as elevated rather than merely optimistic.
The method families split cleanly, and the split is the whole story. Only the growth-DCF family reaches the price: a perpetual-growth DCF lands near $73 and an exit-multiple DCF near $85, both of which credit years of compounding. Every static frame says expensive. The earnings-power value collapses to almost nothing because current normalized earnings are thin, the asset and excess-return methods land in the single digits against a book value of about $5.47 per share, and even the relative-valuation read lands near $44, well below the price, because the trailing P/E is extreme. The blended read across applicable methods is roughly $26, far under the quote. In other words, the price is supported only by methods that assume durable high growth, and contradicted by every method that does not.
The honest conclusion: this is a durability premium, not a value gap. You are paying for compounding that the static frames structurally cannot price, and the premium is reasonable only if Dutch Bros really does sustain high unit growth and healthy traffic-led comps for many years. The same-shop momentum, the mobile and food runway, and the self-funded expansion all support that case operationally. But at 61 times operating income with an 18-year implied horizon, the price already assumes the favorable path. There is little margin for a commodity, labor, or consumer-spending interruption, and the asset and earnings base offer almost no downside support if the growth fades early.
Catalysts
The first-quarter 2026 report was a beat-and-raise. Total revenue rose 31% to $464.4 million, company-operated same-shop sales grew 10.6% with transactions up 6.9%, systemwide same-shop sales of 8.3% were the highest since early 2024, and the company opened 41 new shops to reach 1,177. Adjusted EBITDA grew 26% to $79.4 million. (stocktitan, Investing.com) Management raised the full-year plan to at least 185 new shops and lifted same-store-sales guidance to 4% to 6%, with adjusted EBITDA guided to $370 to $380 million. Notably, the stock dipped after the print despite the raise, a sign of how high the embedded bar is.
Two structural growth levers are the multi-year catalysts. Mobile Order Ahead was roughly 14% of the sales mix at the end of 2025, leaving substantial penetration headroom relative to mature peers, and TD Cowen reiterated a Buy citing mobile as a durable driver. (Investing.com) The food program, after starting in a few Phoenix shops, reached more than 300 shops across 11 states and is set to roll out nationwide by the end of 2026, with early results showing about a 4% comparable-sales lift where it operates. (Restaurant Dive)
Analyst targets have been rising into mid-2026, with DA Davidson at $90, UBS at $85, and TD Cowen at $73. (StocksToTrade) The things that will move the thesis over the next few quarters: whether same-shop comps stay traffic-led as they lap a strong base, the cadence of new-shop openings against the long-term target of about 2,000 shops by 2029, the national food rollout's comp contribution, and any pressure on shop-level margins from coffee, dairy, and labor costs.
Peer Cohorts (Per Segment, With Filing Citations)
Company-operated shops (reported)
- SBUX (Starbucks Corporation)
- (no filing in the citation store)
- CAVA (CAVA Group, Inc.)
- (no filing in the citation store)
- SHAK (SHAKE SHACK INC.)
- (no filing in the citation store)
- WING (WINGSTOP INC.)
- (no filing in the citation store)
- CMG (CHIPOTLE MEXICAN GRILL, INC.)
- (no filing in the citation store)
- DRI (DARDEN RESTAURANTS, INC.)
- (no filing in the citation store)
Franchising and other (reported)
- QSR (RESTAURANT BRANDS INTERNATIONAL INC.)
- (no filing in the citation store)
- YUM (YUM! BRANDS, INC.)
- (no filing in the citation store)
- WEN (Wendy's Co)
- (no filing in the citation store)
- DPZ (DPZ)
- (no filing in the citation store)
- WING (WINGSTOP INC.)
- (no filing in the citation store)
- DRI (DARDEN RESTAURANTS, INC.)
- (no filing in the citation store)
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.